MJBizDaily International Newsletter

Get our international newsletter

More Exclusive Features

Germany’s medical cannabis market prioritizes efficacy over unfettered access

Germany may be the largest and fastest-growing medical cannabis market in Europe, but signs are emerging from medical and regulatory circles that should serve as a warning to marijuana companies planning to commercialize medicines without conclusive clinical trials. In fact, businesses based on science and efficacy may see a competitive advantage in Germany in the […]

Read More

Marijuana, hemp side by side at MJBizConNEXT & Hemp Industry Daily Conference in New Orleans

The cannabis industry is in New Orleans this week for MJBizConNEXT with attendees having the option to specifically focus on either marijuana or hemp – or both, for that matter. That’s because, for the first time, Marijuana Business Daily is hosting side-by-side conferences for both varieties of the cannabis sativa plant, Wednesday-Friday at the Ernest […]

Read More

Despite Italy’s ‘cannabis light’ court ruling, low-THC business continues as usual

The obituary for Italy’s thriving “cannabis light” industry – stemming from an apparently unfavorable court decision – was highly premature, local industry leaders told Marijuana Business Daily. They noted the ruling surrounding low-THC cannabis was ambiguous and the full version is still unavailable. A “cannabis light” industry has been booming in Italy since 2017, when […]

Read More

Aurora, Canopy are Canada’s ‘most reputable’ cannabis firms, survey finds; others rank far behind

Alberta-based Aurora Cannabis edged out Ontario’s Canopy Growth as the most reputable marijuana company in Canada, according to a first-of-its-kind survey by market research firm Leger. The survey – conducted from December 2018 to February 2019 – reflects the reputations of cannabis producers in the opening innings of legalization. The marijuana companies were included as […]

Read More

Deloitte: Canada on verge of CA$2.7 billion infused cannabis market

Canada is on the cusp of prying open a market for edibles and alternative cannabis products valued at 2.7 billion Canadian dollars ($2 billion), but sales will begin as “a slow burn” come October before gaining momentum, Deloitte estimates. For its third annual report on Canada’s cannabis industry, Deloitte conducted in-person interviews with cannabis industry experts, […]

Read More

Cannabis capital ‘rotating’ away from Canada to United States, analyst says

Marijuana businesses and investors seeking higher returns and more potential are looking beyond Canada’s relatively small and highly regulated market, according to analysts covering the still-nascent industry. “Many investors we have spoken to have begun to rotate capital from Canada to the U.S. on the fear that Canadian players will be unable to capture growth […]

Read More

South Africa approves continent’s first federal cannabidiol law

A change to South Africa’s medicines law means the country is the first in Africa to carve out a federally approved market for nonprescription CBD. Health Minister Aaron Motsoaledi amended the country’s Medicines and Related Substances Act, 1965, to remove certain cannabidiol preparations for nonserious health claims on the recommendation of South African Health Products Regulatory […]

Read More